SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-011174
Filing Date
2005-03-15
Accepted
2005-03-15 17:17:04
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-4705_110k.htm 10-K 1507278
2 EX-10.18 a05-4705_1ex10d18.htm EX-10.18 97443
3 EX-10.38 a05-4705_1ex10d38.htm EX-10.38 208671
4 EX-10.39 a05-4705_1ex10d39.htm EX-10.39 43215
5 EX-10.40 a05-4705_1ex10d40.htm EX-10.40 17220
6 EX-23.1 a05-4705_1ex23d1.htm EX-23.1 4617
7 EX-23.2 a05-4705_1ex23d2.htm EX-23.2 2683
8 EX-31.1 a05-4705_1ex31d1.htm EX-31.1 9251
9 EX-31.2 a05-4705_1ex31d2.htm EX-31.2 9327
10 EX-32 a05-4705_1ex32.htm EX-32 6948
11 GRAPHIC g47051fbimage002.gif GRAPHIC 1043
12 GRAPHIC g47051kiimage002.gif GRAPHIC 1207
  Complete submission text file 0001104659-05-011174.txt   1911759
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 05682561
SIC: 2836 Biological Products, (No Diagnostic Substances)